Literature DB >> 17442650

Vaccinating in disease-free regions: a vaccine model with application to yellow fever.

Claudia T Codeço1, Paula M Luz, Flavio Coelho, Alison P Galvani, Claudio Struchiner.   

Abstract

Concerns regarding natural or induced emergence of infectious diseases have raised a debate on the pros and cons of pre-emptive vaccination of populations under uncertain risk. In the absence of immediate risk, ethical issues arise because even smaller risks associated with the vaccine are greater than the immediate disease risk (which is zero). The model proposed here seeks to formalize the vaccination decision process looking from the perspective of the susceptible individual, and results are shown in the context of the emergence of urban yellow fever in Brazil. The model decomposes the individual's choice about vaccinating or not into uncertain components. The choice is modelled as a function of (i) the risk of a vaccine adverse event, (ii) the risk of an outbreak and (iii) the probability of receiving the vaccine or escaping serious disease given an outbreak. Additionally, we explore how this decision varies as a function of mass vaccination strategies of varying efficiency. If disease is considered possible but unlikely (risk of outbreak less than 0.1), delay vaccination is a good strategy if a reasonably efficient campaign is expected. The advantage of waiting increases as the rate of transmission is reduced (low R0) suggesting that vector control programmes and emergency vaccination preparedness work together to favour this strategy. The opposing strategy, vaccinating pre-emptively, is favoured if the probability of yellow fever urbanization is high or if expected R0 is high and emergency action is expected to be slow. In summary, our model highlights the nonlinear dependence of an individual's best strategy on the preparedness of a response to a yellow fever outbreak or other emergent infectious disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442650      PMCID: PMC2396207          DOI: 10.1098/rsif.2007.0234

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  14 in total

Review 1.  [Yellow Fever].

Authors:  Pedro Fernando da Costa Vasconcelos
Journal:  Rev Soc Bras Med Trop       Date:  2003-06-10       Impact factor: 1.581

2.  Risk of fatal adverse events associated with 17DD yellow fever vaccine.

Authors:  C J Struchiner; P M Luz; I Dourado; H K Sato; S G Aguiar; J G L Ribeiro; R C R Soares; C T Codeço
Journal:  Epidemiol Infect       Date:  2004-10       Impact factor: 2.451

3.  Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial.

Authors:  Luiz Antonio Bastos Camacho; Marcos da Silva Freire; Maria da Luz Fernandes Leal; Savitri Gomes de Aguiar; Jussara Pereira do Nascimento; Takumi Iguchi; José de Azevedo Lozana; Roberto Henrique Guedes Farias
Journal:  Rev Saude Publica       Date:  2004-10-18       Impact factor: 2.106

4.  Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil.

Authors:  Amber R Engel; Pedro F C Vasconcelos; Monica A McArthur; Alan D T Barrett
Journal:  Vaccine       Date:  2006-01-18       Impact factor: 3.641

5.  Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial.

Authors:  Luiz Antonio Bastos Camacho; Savitri Gomes de Aguiar; Marcos da Silva Freire; Maria da Luz Fernandes Leal; Jussara Pereira do Nascimento; Takumi Iguchi; José Azevedo Lozana; Roberto Henrique Guedes Farias
Journal:  Rev Saude Publica       Date:  2005-06-30       Impact factor: 2.106

6.  Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil.

Authors:  R Galler; K V Pugachev; C L Santos; S W Ocran; A V Jabor; S G Rodrigues; R S Marchevsky; M S Freire; L F Almeida; A C Cruz; A M Yamamura; I M Rocco; E S da Rosa; L T Souza; P F Vasconcelos; F Guirakhoo; T P Monath
Journal:  Virology       Date:  2001-11-25       Impact factor: 3.616

7.  The risk of yellow fever in a dengue-infested area.

Authors:  E Massad; F A Coutinho; M N Burattini; L F Lopez
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Jul-Aug       Impact factor: 2.184

8.  Oral susceptibility to yellow fever virus of Aedes aegypti from Brazil.

Authors:  Ricardo Lourenço-de-Oliveira; Marie Vazeille; Ana Maria Bispo de Filippis; Anna-Bella Failloux
Journal:  Mem Inst Oswaldo Cruz       Date:  2002-04       Impact factor: 2.743

9.  Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys.

Authors:  Renato S Marchevsky; Marcos S Freire; Evandro S F Coutinho; Ricardo Galler
Journal:  Virology       Date:  2003-11-10       Impact factor: 3.616

10.  Uncertainties regarding dengue modeling in Rio de Janeiro, Brazil.

Authors:  Paula Mendes Luz; Cláudia Torres Codeço; Eduardo Massad; Claudio José Struchiner
Journal:  Mem Inst Oswaldo Cruz       Date:  2003-10       Impact factor: 2.743

View more
  10 in total

1.  Assessing the risk of international spread of yellow fever virus: a mathematical analysis of an urban outbreak in Asuncion, 2008.

Authors:  Michael A Johansson; Neysarí Arana-Vizcarrondo; Brad J Biggerstaff; Nancy Gallagher; Nina Marano; J Erin Staples
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

Review 2.  Modelling the influence of human behaviour on the spread of infectious diseases: a review.

Authors:  Sebastian Funk; Marcel Salathé; Vincent A A Jansen
Journal:  J R Soc Interface       Date:  2010-05-26       Impact factor: 4.118

3.  Incubation periods of Yellow fever virus.

Authors:  Michael A Johansson; Neysarí Arana-Vizcarrondo; Brad J Biggerstaff; J Erin Staples
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

4.  Dynamic modeling of vaccinating behavior as a function of individual beliefs.

Authors:  Flávio Codeço Coelho; Claudia T Codeço
Journal:  PLoS Comput Biol       Date:  2009-07-10       Impact factor: 4.475

5.  Enrollment in YFV Vaccine Trial: An Evaluation of Recruitment Outcomes Associated with a Randomized Controlled Double-Blind Trial of a Live Attenuated Yellow Fever Vaccine.

Authors:  Paula M Frew; Eve T Shapiro; Lu Lu; Srilatha Edupuganti; Harry L Keyserling; Mark J Mulligan
Journal:  Trop Med Surg       Date:  2013-04-15

6.  Habitat fragmentation promotes malaria persistence.

Authors:  Daozhou Gao; P van den Driessche; Chris Cosner
Journal:  J Math Biol       Date:  2019-09-13       Impact factor: 2.259

Review 7.  Modeling transmission dynamics and control of vector-borne neglected tropical diseases.

Authors:  Paula M Luz; Claudio J Struchiner; Alison P Galvani
Journal:  PLoS Negl Trop Dis       Date:  2010-10-26

8.  Evolutionary game theory and social learning can determine how vaccine scares unfold.

Authors:  Chris T Bauch; Samit Bhattacharyya
Journal:  PLoS Comput Biol       Date:  2012-04-05       Impact factor: 4.475

9.  A computational approach to characterizing the impact of social influence on individuals' vaccination decision making.

Authors:  Shang Xia; Jiming Liu
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

10.  Strategic decision making about travel during disease outbreaks: a game theoretical approach.

Authors:  Shi Zhao; Chris T Bauch; Daihai He
Journal:  J R Soc Interface       Date:  2018-09-12       Impact factor: 4.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.